Search Results - "Santomé, Lucía"

Evaluation of the lung immune prognostic index in advanced non-small cell lung cancer patients under nivolumab monotherapy by Ruiz-Bañobre, Juan, Areses-Manrique, María C., Mosquera-Martínez, Joaquín, Cortegoso, Alexandra, Afonso-Afonso, Francisco J., de Dios-Álvarez, Noemí, Fernández-Núñez, Natalia, Azpitarte-Raposeiras, Cristina, Amenedo, Margarita, Santomé, Lucía, Fírvida-Pérez, José Luis, García-Campelo, Rosario, García-González, Jorge, Casal-Rubio, Joaquín, Vázquez, Sergio

“…The lung immune prognostic index (LIPI) has been proposed as a new categorical blood-based biomarker to select advanced non-small cell lung cancer (NSCLC)…”
Get full text

Real-world data with afatinib in Spanish patients with treatment-naïve non-small-cell lung cancer harboring exon 19 deletions in epidermal growth factor receptor (Del19 EGFR): Clinical experience of the Galician Lung Cancer Group by Agraso, Sara, Lázaro, Martin, Firvida, Xose Luis, Santomé, Lucía, Fernández, Natalia, Azpitarte, Cristina, Leon, Luis, Garcia, Carme, Hudobro, Gerardo, Areses, Ma Carmen, Campos, Begoña, Quiroga, Nazaret, García, Jorge, Casal, Joaquín

“…•Real-world study of first-line afatinib in patients with Del19 EGFR NSCLC.•Treatment-naïve patients with Del19 EGFR NSCLC reported long PFS with…”
Get full text

EGFR testing and clinical management of advanced NSCLC: a Galician Lung Cancer Group study (GGCP 048-10) by Vázquez, Sergio, Casal, Joaquín, Afonso Afonso, Francisco Javier, Fírvida, José Luis, Santomé, Lucía, Barón, Francisco, Lázaro, Martín, Pena, Carolina, Amenedo, Margarita, Abdulkader, Ihab, González-Arenas, Carmen, Fachal, Laura, Vega, Ana

“…This study aimed to assess the incidence of mutations in the epidermal growth factor receptor (EGFR) gene in non-small-cell lung cancer (NSCLC) patients in the…”
Get full text

Real world data of nivolumab for previously treated non-small cell lung cancer patients: a Galician lung cancer group clinical experience by Areses Manrique, Mª Carmen, Mosquera Martínez, Joaquín, García González, Jorge, Afonso Afonso, Francisco Javier, Lázaro Quintela, Martín, Fernández Núñez, Natalia, Azpitarte Raposeiras, Cristina, Amenedo Gancedo, Margarita, Santomé Couto, Lucía, García Campelo, Mª Rosario, Muñoz Iglesias, Jose, Cortegoso Mosquera, Alexandra, Vilchez Simo, Rocío, Casal Rubio, Joaquín, Campos Balea, Begoña, Carou Frieiro, Iria, Alonso-Jaudenes Curbera, Guillermo, Anido Herranz, Urbano, García Mata, Jesus, Fírvida Pérez, José Luis

Get full text

Fluorescence in situ hybridization analysis of the ALK gene in 2,045 non-small cell lung cancer patients from North-Western Spain (Galicia) by Sánchez-Ares, María, Cameselle-Teijeiro, José M, Vázquez-Estévez, Sergio, Lázaro-Quintela, Martín, Vázquez-Boquete, Ángel, Afonso-Afonso, Francisco J, Casal-Rubio, Joaquín, González-Piñeiro, Ana L, Rico-Rodríguez, Yolanda, Fírvida-Pérez, José L, Ruíz-Bañobre, Juan, Couso, Elena, Santomé, Lucía, Pérez-Becerra, Raquel, García-Campelo, Rosario, Amenedo, Margarita, Azpitarte-Raposeiras, Cristina, Antúnez, José, Abdulkader, Ihab

“…Identification of anaplastic lymphoma receptor tyrosine kinase (ALK) gene rearrangements is a standard diagnostic test in patients with advanced non-small cell…”
Get full text

Radium-223 for mCRPC, a real-world experience study from 7 Galician medical centers by Anido Herranz, Urbano, Fernandez Calvo, Ovidio, Martinez Breijo, Sara, Fernández Núñez, Natalia, Nogareda Seoane, Zulema, Garrido Pumar, Miguel, Casas, Javier, Muñiz Garcia, Gloria, Portela Pereira, Paula, Gomez Caamaño, Antonio, Pérez Fentes, Daniel, Santomé, Lucía, Huidobro Vence, Gerardo, Molina Díaz, Aurea, Medina, Ana, Ruiz Bañobre, Juan, Vázquez Estévez, Sergio

“…96 Background: Radium-223 represents an option for symptomatic metastatic castration-resistant prostate cancer (mCRPC) after demonstrated an overall survival…”
Get full text

Galician lung cancer group: Afatinib´s data as first-line treatment for elderly patients by Agraso Busto, Sara, Varela, Vanesa, Fernández Núñez, Natalia, Firvida, Jose-luis, Santomé, Lucía, Afonso, Francisco Javier, Azpitarte, Cristina, De Dios Alvarez, Noemi, Garcia, Jorge, Campos Balea, Begoña, Areses Manrique, Maria Carmen, Pereiro Corbacho, Diego, Huidobro, Gerardo, Lazaro Quintela, Martin, Casal Rubio, Joaquín

“…Abstract only e20662 Background: There are scarcy data or studies on safety and efficacy of afatinib in elderly patients. Methods: Retrospective study on…”
Get full text

Utility of the Lung Immune Prognostic Index (LIPI) in prognostication and disease control prediction in advanced NSCLC patients treated with nivolumab by Ruiz Bañobre, Juan, Areses Manrique, María C., García Campelo, Rosario, Lopez, Rafael, Afonso Afonso, Francisco J., Casal Rubio, Joaquín, Vázquez Estévez, Sergio, Raposeiras, Cristina Azpitarte, Amenedo, Margarita, Santomé, Lucía, Fírvida Pérez, José Luis, Mosquera Martínez, Joaquín, Cortegoso, Alexandra, Vilchez Simó, Rocío, Huidobro Vence, Gerardo, Fernández Núñez, Natalia, Quiroga Veiga, Nazaret, García Mata, Jesús, Alonso-Jáudenes Curbera, Guillermo, Anido Herranz, Urbano

“…Abstract only e20645 Background: The lung immune prognostic index (LIPI) has been proposed as a new biomarker to select advanced non-small cell lung cancer…”
Get full text

Real-world clinical experience of the Galician Lung Cancer Group: Afatinib in patients with EGFR positive mutation by Agraso Busto, Sara, Varela, Vanesa, Fernández Núñez, Natalia, Firvida, Jose-luis, Santomé, Lucía, Afonso, Francisco Javier, Azpitarte, Cristina, De Dios Alvarez, Noemi, Garcia, Jorge, Campos Balea, Begoña, Areses Manrique, Maria Carmen, Pereiro Corbacho, Diego, Huidobro, Gerardo, Lazaro Quintela, Martin, Casal Rubio, Joaquín

“…Abstract only e20654 Background: Treatment with tyrosine kinasa inhibitors has been a revolution for the patients with non-small cell lung cancer and EGFR…”
Get full text

The real-world experience with nivolumab in previously treated patients with advanced non small cell lung cancer (NSCLC): A Galician Lung Cancer Group clinical practice by Areses, MC, Campelo, Rosario Garcia, García González, Jorge, Afonso, Francisco Javier, Lazaro, Martin Emilio, Campos, Begoña, Azpitarte, Cristina, Amenedo, Margarita, Santomé, Lucía, Ron, David Arias, Alonso-Jaudenes, Guillermo, Baron, Francisco, Vilchez, Rocio, Casal, Joaquin, Fernandez, Natalia, Carou, Iria, Mosquera, Joaquin, Anido, Urbano, Garcia Mata, Jesus, Firvida, Jose-luis

“…Abstract only e20564 Background: Nivolumab, was the first checkpoint inhibitor to show a survival benefit in previously treated patients with advanced NSCLC in…”
Get full text

Long-term progression-free survival (PFS) in patients under sunitinib treatment: A SOG_GU experience by Afonso, Francisco Javier, Calvo, Ovidio Fernández, Esteban, Emilio, Fernández Gabriel, Elena, Vazquez-Estevez, Sergio, Anido, Urbano, Lázaro Quintela, Martin, Santomé, Lucía, Ramos Vazquez, Manuel, Campos Balea, Begoña, Leon Mateos, Luis, Firvida, Jose-luis, Aparicio, Luis Anton

“…Abstract only e15067 Background:A multicenter retrospective analysis was performed in patients (pts) with metastatic RCC treated with sunitinib who achieved…”
Get full text

Expression of Notch family members in stage IV renal cell carcinoma tumors: Notch1 as medium-risk prognosis factor by Antón Aparicio, Luis M., Medina Villaamil, Vanessa, Aparicio Gallego, Guadalupe, Quindós Varela, Maria, Vazquez-Estevez, Sergio, Leon Mateos, Luis, Afonso Afonso, Francisco J., Firvida Perez, Jose Luis, Ramos Vazquez, Manuel, Calvo, Ovidio Fernández, Santomé, Lucía, Lázaro Quintela, Martin, Santamarina Cainzos, Isabel, Anido, Urbano

“…Abstract only e15076 Background: The characterization of factors involved in the etiology of renal cell carcinoma (RCC) may lead to the identification of new…”
Get full text

Analysis of the expression of Wnt signaling ligands in metastatic renal cell carcinomas tissue samples by Anido, Urbano, Medina Villaamil, Vanessa, Aparicio Gallego, Guadalupe, Quindós Varela, Maria, Vazquez-Estevez, Sergio, Leon Mateos, Luis, Afonso Afonso, Francisco J., Ramos Vazquez, Manuel, Firvida Perez, Jose Luis, Santomé, Lucía, Calvo, Ovidio Fernández, Lázaro Quintela, Martin, Santamarina Cainzos, Isabel, Antón Aparicio, Luis M.

“…Abstract only e15077 Background: Renal cell carcinomas (RCC) constitute a morphologically and genetically heterogeneous tumor.Wnt proteins are a large family…”
Get full text

Metastatic Bladder Cancer: Second-Line Treatment and Recommendations of the Genitourinary Tumor Division of the Galician Oncologic Society (SOG-GU) by García, Jorge, Santomé, Lucia, Anido, Urbano, Fernández-Calvo, Ovidio, Afonso-Afonso, Javier, Lázaro, Martín, Medina, Ana, Vázquez Estévez, Sergio

“…Once metastatic bladder cancer has progressed to first-line treatment, the number of therapeutic options is scarce. Among chemotherapeutic agents showing…”
Get full text

Enzalutamide: A new prostate cancer targeted therapy against the androgen receptor by Quintela, Martín Lázaro, Mateos, Luis León, Estévez, Sergio Vázquez, Calvo, Ovidio Fernández, Herranz, Urbano Anido, Afonso, Francisco Javier Afonso, Santomé, Lucía, Aparicio, Luis Antón

“…Highlights • The AR signalling pathway is a crucial element in the natural history of mCRPC. • Enzalutamide has a much higher binding affinity to the AR than…”
Get full text

Second-line treatment in advanced non-small-cell lung cancer in the epidermal growth factor receptor wild-type population: review of patient profile by Vázquez, Sergio, Lázaro, Martín, Fírvida, José Luis, Santomé, Lucía, Afonso, Javier, Amenedo, Margarita, Casal, Joaquín

“…After progression during first-line treatment in advanced non-small-cell lung cancer (NSCLC), a large percentage of patients are candidates for second-line…”
Get full text

Outcomes and patterns of use of Radium-223 in metastatic castration-resistant prostate cancer by Anido-Herranz, Urbano, Fernandez-Calvo, Ovidio, Ruiz-Bañobre, Juan, Martinez-Breijo, Sara, Fernandez-Nuñez, Natalia, Nogareda-Seoane, Zulema, Garrido-Pumar, Miguel, Casas-Nebra, Javier, Muñiz-Garcia, Gloria, Portela-Pereira, Paula, Gomez-Caamaño, Antonio, Perez-Fentes, Daniel Adolfo, Santome-Couto, Lucia, Lázaro, Martín, Molina-Diaz, Aurea, Medina-Colmenero, Ana, Vazquez-Estevez, Sergio

“…Radium-223 dichloride (Ra-223) is recommended as a treatment option for metastatic castration-resistant prostate cancer (mCRPC) patients with symptomatic bone…”
Get full text

First-line bevacizumab, cisplatin and vinorelbine plus maintenance bevacizumab in advanced non-squamous non-small cell lung cancer chemo-naïve patients by Leon, Luis, Vázquez, Sergio, Gracia, José Manuel, Casal, Joaquín, Lazaro, Martín, Firvida, José Luis, Amenedo, Margarita, Santome, Lucia, Macia, Sonia

“…The aim of this study was to evaluate efficacy and safety of first-line treatment with bevacizumab, cisplatin and vinorelbine and bevacizumab maintenance in…”
Get more information

Prostate cancer perspectives after chaarted: Optimizing treatment sequence by Macia, Sonia, Estévez, Sergio Vázquez, Herranz, Urbano Anido, Calvo, Ovidio Fernández, Afonso, Francisco Javier, Couto, Lucía Santomé, Quintela, Martín Lázaro, Mateos, Luis León, Aparicio, Luis Miguel Antón

“…Abstract Prostate cancer is the most frequent cancer amongst men. Until recently, only two therapeutic options, initial androgen-deprivation therapy in…”
Get full text

PD-(L)1 Inhibitors in Combination with Chemotherapy as First-Line Treatment for Non-Small-Cell Lung Cancer: A Pairwise Meta-Analysis by García-González, Jorge, Ruiz-Bañobre, Juan, Afonso-Afonso, Francisco J, Amenedo-Gancedo, Margarita, Areses-Manrique, María Del Carmen, Campos-Balea, Begoña, Casal-Rubio, Joaquín, Fernández-Núñez, Natalia, Fírvida Pérez, José Luis, Lázaro-Quintela, Martín, Pérez Parente, Diego, Crama, Leonardo, Ruiz-Gracia, Pedro, Santomé-Couto, Lucía, León-Mateos, Luis

“…The combination of programmed cell death-1 (PD-1)/programmed death ligand-1 (PD-L1) inhibitors with chemotherapy has emerged as a promising therapeutic option…”
Get full text